Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Orlent H, Hansen B, Janssen HLA, De Knegt RJ. High-dose (peg)interferon therapy in treatment-naïve, interleukin-28B rs12979860 CT/TT genotype 1 chronic hepatitis C. Dig Liver Dis 2015;47:87-8. [PMID: 25308611 DOI: 10.1016/j.dld.2014.09.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/17/2014] [Revised: 08/28/2014] [Accepted: 09/10/2014] [Indexed: 12/11/2022]

For:	Orlent H, Hansen B, Janssen HLA, De Knegt RJ. High-dose (peg)interferon therapy in treatment-naïve, interleukin-28B rs12979860 CT/TT genotype 1 chronic hepatitis C. Dig Liver Dis 2015;47:87-8. [PMID: 25308611 DOI: 10.1016/j.dld.2014.09.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/17/2014] [Revised: 08/28/2014] [Accepted: 09/10/2014] [Indexed: 12/11/2022]

Number	Cited by Other Article(s)
1	Montagner IM, Merlo A, Carpanese D, Dalla Pietà A, Mero A, Grigoletto A, Loregian A, Renier D, Campisi M, Zanovello P, Pasut G, Rosato A. A site-selective hyaluronan-interferonα2a conjugate for the treatment of ovarian cancer. J Control Release 2016;236:79-89. [DOI: 10.1016/j.jconrel.2016.06.033] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2015] [Revised: 06/23/2016] [Accepted: 06/24/2016] [Indexed: 12/16/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Montagner IM, Merlo A, Carpanese D, Dalla Pietà A, Mero A, Grigoletto A, Loregian A, Renier D, Campisi M, Zanovello P, Pasut G, Rosato A. A site-selective hyaluronan-interferonα2a conjugate for the treatment of ovarian cancer. J Control Release 2016;236:79-89. [DOI: 10.1016/j.jconrel.2016.06.033] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2015] [Revised: 06/23/2016] [Accepted: 06/24/2016] [Indexed: 12/16/2022]